- PR Newswire•13 days agoNanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials
SHELTON, Conn., Oct. 11, 2016 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), reports that it has filed its financial year end annual report (Form 10-K) with the Securities and Exchange Commission (SEC) on Friday, September 16, 2016 in a timely manner. NanoViricides, Inc. is a global leader in the application of nanomedicine technologies to the complex issues of viral diseases. The nanoviricide® technology enables direct attacks at multiple points on a virus particle.
- PR Newswire•last monthNanoViricides to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City Today
SHELTON, Conn., Sept. 13, 2016 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), a global leader in nanomedicines that is developing biomimetic anti-viral drugs announced that it will be featured as a presenting company today at the 18th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 11-13, 2016, at Lotte New York Palace Hotel in New York City. Eugene Seymour, MD, MPH, CEO of NanoViricides, will provide an overview of the Company's business and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. Dr Seymour's presentation is scheduled for 10am on Tuesday, September 13th, in the Holmes-I conference room. If you are an institutional investor, and would like to attend the Company's presentation, please click the link www.rodmanevents.com to register for the Rodman & Renshaw conference.
- PR Newswire•2 months ago
SHELTON, Conn., Aug. 25, 2016 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), a global leader in nanomedicines that is developing biomimetic anti-viral drugs reports that Honorable U.S. Senator Chris Murphy visited the Company's new campus in Shelton, CT, on Wednesday, August 24th, 2016. "NanoViricides is exactly the type of innovative company that is driving job creation throughout greater New Haven and the Naugatuck Valley," said Senator Murphy, adding, "I was incredibly impressed by the company and enjoyed hearing from employees during my town hall about how I can best help them and other bioscience entrepreneurs cut through red tape.
NanoViricides, Inc. (NNVC)
NYSE MKT - NYSE MKT Real Time Price. Currency in USD
|Bid||1.50 x 100|
|Ask||1.51 x 200|
|Day's Range||1.47 - 1.55|
|52wk Range||0.96 - 3.44|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-8.24|
|Avg Vol (3m)||63,160|
|Dividend & Yield||N/A (N/A)|